Quanterix (QTRX) Cash from Investing Activities (2017 - 2026)
Quanterix's (QTRX) quarterly Cash from Investing Activities came in at $25.3 million in Q1 2026, down 22.89% YoY from $32.8 million in Q1 2025, and up 199.36% on a QoQ basis from $8.4 million in Q4 2025.
Quanterix (QTRX) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Cash from Investing Activities data on file, last reported at $25.3 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 22.89% year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.7 million (down 28.41% YoY) and the FY2025 annual result came in at $50.2 million, up 161.06% from the prior year.
- Cash from Investing Activities advanced to $25.3 million in Q1 2026, from $8.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $61.9 million in Q2 2025 to a low of -$126.1 million in Q3 2023.
- A 5-year average of -$9.8 million and a median of -$815000.0 in 2022 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 960.05% in 2024, down 80190.44% in 2024.
- Tracing QTRX's Cash from Investing Activities over 5 years: stood at -$1.6 million in 2022, then sank by 1240.19% to -$21.4 million in 2023, then jumped by 251.5% to $32.4 million in 2024, then plunged by 73.94% to $8.4 million in 2025, then surged by 199.36% to $25.3 million in 2026.
- The last three Cash from Investing Activities figures came in at $25.3 million (Q1 2026), $8.4 million (Q4 2025), and -$52.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn | 13.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.66 Mn |
| Jun 30, 2026 | 13.66 Mn |
| Mar 31, 2026 | 25.26 Mn |
| Mar 31, 2026 | 25.26 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Sep 30, 2025 | -52.85 Mn |
| Sep 30, 2025 | -52.85 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Mar 31, 2025 | 32.76 Mn |
| Mar 31, 2025 | 32.76 Mn |
| Dec 31, 2024 | 32.38 Mn |
| Dec 31, 2024 | 32.38 Mn |
| Sep 30, 2024 | -12.43 Mn |
| Sep 30, 2024 | -12.43 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Mar 31, 2024 | -109.20 Mn |
| Mar 31, 2024 | -109.20 Mn |